Loading the map…
Research and experimental development on biotechnology · Farnham
Molecular Medical
Molecular Medical Ltd
Private limited company registered in Farnham, classed under “Research and experimental development on biotechnology”.
Headline figures
FY to Dec 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
2 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2021* | 2022 | 2023 | 2024* | 2025 |
|---|---|---|---|---|---|
| Profit after tax | — | ||||
| Turnover | |||||
| Net assets | |||||
| Cash | |||||
| Employees | |||||
| Retained reserves |
Every figure for all 5 years
“—” means we did not find the figure in a source; it is never filled with an estimate. * Restated: the next year's accounts printed different figures for this year, and those later figures are shown.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current assets | ||||
| of which debtors | ||||
| of which cash | ||||
| Creditors due within a year | ||||
| Net current assets | ||||
| Creditors due after a year | ||||
| Net assets | ||||
| Ratios | ||||
| Current ratioCurrent assets for every £1 owed within a year | ||||
| Cash ratioCash for every £1 owed within a year | ||||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||||
7 balance-sheet lines and 3 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-10-29
- AccountsTotal exemption full accounts made up to 31 December 2025
- AccountsAmended total exemption full accounts made up to 31 December 2024
- AccountsTotal exemption full accounts made up to 31 December 2024
- AccountsTotal exemption full accounts made up to 31 December 2023
- AccountsPrevious accounting period shortened from 31 December 2023 to 30 December 2023
- AccountsTotal exemption full accounts made up to 31 December 2022
- AccountsMicro company accounts made up to 31 December 2021
- SharesStatement of capital following an allotment of shares on 10 December 2022 · GBP 100.00
- SharesSub-division of shares on 10 December 2022
- FilingMemorandum and Articles of Association
- FilingResolutions
- SharesChange of share class name or designation
5 earlier
- OwnershipNotification of Pedro Garcia as a person with significant control on 10 December 2022
- DirectorsAppointment of Mr Pedro Garcia as a director on 11 December 2022
- OwnershipChange of details for Dr Sean Leo Willis as a person with significant control on 10 December 2022
- AccountsPrevious accounting period shortened from 28 February 2022 to 31 December 2021
- IncorporationIncorporation
- Ownership
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Molecular Medical do?
Private limited company registered in Farnham, classed under “Research and experimental development on biotechnology”.
›How much turnover does Molecular Medical make?
Answered in the full report
›Is Molecular Medical profitable?
Molecular Medical's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Molecular Medical?
Answered in the full report
›Who runs and owns Molecular Medical?
Its directors are Pedro Garcia, Sean Leo Willis. Its owners are shown to subscribers.
›Where is Molecular Medical based?
Its registered office is 2 Glenwood Villas Fifield Lane, Frensham, Farnham, GU10 3AR, in Farnham.
›When was Molecular Medical founded?
Molecular Medical Ltd was incorporated on 24 February 2021.
›Is Molecular Medical still trading?
The register lists Molecular Medical Ltd as active.